Home
Careers
Media
Contact us
Corporate Profile
Vision & Mission
History
Board of Directors
Certifications
Group Companies
Active Pharmaceutical Ingredients
Bulk Pharma Chemicals
Phosgene
Intermediates
Formulations
International
Domestic
Branded Formulations
Generic
Herbal Nutraceuticals
Veterinary
Contract / Collaborated Research Services
Alembic Research Center
Quality
Regulatory Affairs
Objectives
Activities
Macrolide Chemistry
Corporate Citizenship
Environment
Community
Corporate Overview
Letter from the Chairman
Stock Quote
Code of Conduct
Shareholding Pattern
Financial Results
Annual Report
Quarterly Reports
Events & Presentation
Investor Corner
Investor Presentation
Bifurcation of cost of Acquisition
Investor Presentation
Title
PDF
Investor Presentation March 2012
3.1 MB
Investors
Corporate Overview
Letter from the Chairman
Stock Quote
Code of Conduct
Shareholding Pattern
Financial Results
Events & Presentation
Investor Corner
Investor Presentation
Bifurcation of cost of Acquisition
